TY - JOUR T1 - De novo 911 Kb interstitial deletion on chromosome 1q43 in a boy with mental retardation and short stature. JF - Eur J Med Genet Y1 - 2012 A1 - Perrone, M D A1 - Rocca, M S A1 - Bruno, I A1 - Faletra, F A1 - Pecile, V A1 - Gasparini, P KW - Child KW - Chromosomes, Human, Pair 1 KW - Dwarfism KW - Humans KW - Intellectual Disability KW - Male KW - Sequence Deletion AB -

Patients with distal deletions of chromosome 1q have a recognizable syndrome that includes microcephaly, hypoplasia or agenesis of the corpus callosum, and psychomotor retardation. Although these symptoms have been attributed to deletions of 1q42-1q44, the minimal chromosomal region involved has not yet defined. In this report, we describe a 7 years old male with mental retardation, cryptorchid testes, short stature and alopecia carrying only an interstitial de novo deletion of 911 Kb in the 1q43 region (239,597,095-240,508,817) encompassing three genes CHRM3, RPS7P5 and FMN2.

VL - 55 IS - 2 U1 - http://www.ncbi.nlm.nih.gov/pubmed/22186213?dopt=Abstract ER - TY - JOUR T1 - Identification of a New Mutation (L46P) in the Human NOG Gene in an Italian Patient with Symphalangism Syndrome. JF - Mol Syndromol Y1 - 2012 A1 - Athanasakis, E A1 - Biarnés, X A1 - Bonati, M T A1 - Gasparini, P A1 - Faletra, F AB -

Proximal symphalangism (SYM1) is a joint morphogenesis disorder characterized by stapes ankylosis, proximal interphalangeal joint fusion, skeletal anomalies and conductive hearing loss. Noggin is a bone morphogenetic protein (BMP) antagonist essential for normal bone and joint development in humans and mice. Autosomal dominant mutations have been described in the NOG gene, encoding the noggin protein. We analyzed an Italian sporadic patient with SYM1 due to a novel NOG mutation (L46P) based on a c.137T>C transition. A different pathogenic mutation in the same codon (L46D) has been previously described in an in vivo chicken model. An in silico model shows a decreased binding affinity between noggin and BMP7 for both L46D and L46P compared to the wild type. Therefore, this codon should play an important role in BMP7 binding activity of the noggin protein and consequently to the joint morphogenesis.

VL - 3 IS - 1 U1 - http://www.ncbi.nlm.nih.gov/pubmed/22855651?dopt=Abstract ER - TY - JOUR T1 - Phylloid pattern of hypomelanosis closely related to chromosomal abnormalities in the 13q detected by SNP array analysis. JF - Dermatology Y1 - 2012 A1 - Faletra, F A1 - Berti, I A1 - Tommasini, A A1 - Pecile, V A1 - Cleva, L A1 - Alberini, E A1 - Bruno, I A1 - Gasparini, P KW - Chromosomes, Human, Pair 13 KW - Humans KW - Hypopigmentation KW - Male KW - Mosaicism KW - Oligonucleotide Array Sequence Analysis KW - Polymorphism, Single Nucleotide AB -

Phylloid hypomelanosis is a distinct type of pigmentary mosaicism characterized by congenital hypochromic macules resembling a floral ornament with various elements such as round or oval patches, asymmetrical macules similar to begonia leaves, or oblong lesions. It has been found to be predominantly associated with abnormalities in chromosome 13 and sometimes as-sociated with different extracutaneous abnormalities. Here, we report 2 new cases of phylloid hypomelanosis due to mosaicism involving chromosome 13. The first one is a mosaicism for a supernumerary marker belonging to chromosome 13 and the second one is the first report of phylloid hypomelanosis associated with a mosaic deletion of 13q. Because of the extremely low level of mosaicism in these 2 cases, SNP array analysis on skin fibroblasts was carried out, showing a 13q21.33-q34 duplication (71,024,411-115,103,529) and a 13q13.3-q34 (38,368,012-115,103,529) deletion. Both cases underline on the one hand the strict connection between phylloid hypomelanosis and anomalies of chromosome 13, and on the other hand the relevance of the SNP array analysis on skin fibroblasts in the detection of low-level mosaicism.

VL - 225 IS - 4 U1 - http://www.ncbi.nlm.nih.gov/pubmed/23095783?dopt=Abstract ER - TY - JOUR T1 - Two Novel COH1 Mutations in an Italian Patient with Cohen Syndrome. JF - Mol Syndromol Y1 - 2012 A1 - Athanasakis, E A1 - Fabretto, A A1 - Faletra, F A1 - Mocenigo, M A1 - Morgan, A A1 - Gasparini, P AB -

Cohen syndrome (CS) is an autosomal recessive disease caused by mutations in the COH1 gene. It is characterized by intellectual disability, hypotonia, joint hyperlaxity, severe myopia, characteristic facial dysmorphisms and, in some cases, intermittent isolated neutropenia. We investigated an Italian patient with CS together with his family. Genetic analysis disclosed 2 novel mutations: the first is an intronic mutation (c.8697-9A>G) creating a new splice site 8 nucleotides upstream, and the second is a duplication of 1 base (c.10156dupA) generating a premature stop codon. The compound heterozygous mutations explain the proband's phenotype and improved the knowledge of genotype-phenotype correlation.

VL - 3 IS - 1 U1 - http://www.ncbi.nlm.nih.gov/pubmed/22855652?dopt=Abstract ER -